Immunology and Microbiology
Immunodeficiency
100%
Autoimmunity
100%
B Cell
100%
Common Variable Immunodeficiency
55%
Transmembrane Activator and CAML Interactor
44%
T Cell
44%
Precursor
33%
Myeloid
33%
Natural Killer Cell
22%
Hypogammaglobulinemia
22%
Maturation
22%
Knockout Mouse
22%
B Cell Activating Factor
22%
Campylobacter
11%
Lineages
11%
Mitogen
11%
B Cell Development
11%
Severe Combined Immunodeficiency
11%
Immunoglobulin M
11%
Autoantibodies
11%
Adoptive Immunity
11%
Humoral Immunity
11%
Cytotoxic T-Cell
11%
Immunoglobulin A
11%
Lymphoid Organ
11%
Viral Disease
11%
Cytomegalovirus
11%
TNFRSF13B
11%
CD4
11%
Lichen Planus
11%
CD4 CD8 Ratio
11%
Haemophilus influenzae
11%
Autoimmune Regulator
11%
Cytokine Antibody
11%
Shigella
11%
Human Cytomegalovirus
11%
Transcription Factors
11%
Hematopoiesis
11%
Colorectal Cancer Cell Line
11%
Missense Mutation
11%
Immunopathology
11%
Salmonella
11%
Intravenous Immunoglobulin
11%
Immune Response
11%
Somatic Mutation
11%
Promoter Region
11%
Lymphocytopenia
11%
Cell Function
11%
Thymus Hyperplasia
11%
Tumor Necrosis Factor Receptor
11%
Stop Codon
11%
Phytohaemagglutinin
11%
Opportunistic Infection
11%
Cytokine
11%
Myasthenia gravis
11%
Infectious Agent
11%
Airway
11%
Immune System
11%
Virus
11%
Immunoglobulin
11%
Streptococcus Pneumonia
11%
Immunoglobulin Class Switching
11%
Primary Immunodeficiency
11%
Keyphrases
Good's Syndrome
100%
Autoimmunity
50%
Immunodeficiency
50%
Thymoma
20%
Common Variable Immunodeficiency
12%
Transmembrane
10%
New England Journal of Medicine
5%
Autoimmune Syndrome
5%
B Cell Abnormalities
5%
Long-term Prognosis
5%
Local Complications
5%
Acute Lymphoblastic Leukemia
5%
Hypogammaglobulinemia
5%
T Cells
5%
BAFF-R
5%
B Lymphocytes
5%
Autoimmune Regulator
5%
Cell Arrest
5%
Immunodeficiency Diseases
5%
Anticytokine Antibodies
5%
NK Cell Dysfunction
5%
Peripheral B Cells
5%
Thymectomy
5%
Pre-B Cells
5%
Polygenic Disease
5%
Myasthenia Gravis
5%
Thymic Hyperplasia
5%
Molecular Abnormalities
5%
Pure Red Cell Aplasia
5%
Oral Lichen Planus
5%
Immunoglobulin Replacement Therapy (IgRT)
5%
Orphan Drugs
5%
TNFRSF13B
5%
Lymphoid Lineage
5%
T Cell Mitogen
5%
Sinus
5%
T Cell Precursors
5%
Adult-onset Immunodeficiency
5%
Encapsulated Bacteria
5%